Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$6.27B
sum of reported positions
Reported positions
833
Changes vs prior quarter
994
141 new · 267 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 299 measured positions in 6 quarters, the typical new or larger position finished −3.3 pts against the S&P 500 and 39% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 1.05M | $146M | 2.3% | |
| 333K | $83.8M | 1.3% | |
| 223K | $76.6M | 1.2% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $6.73B | $6.27B |
| Positions | 959 | 833 |
| Biggest line | — | Intel 2% |
| 957K |
| $74.9M |
| 1.2% |
| 403K | $73M | 1.2% |
| 696K | $71.2M | 1.1% |
| 76K | $70.7M | 1.1% |
| 176K | $69.9M | 1.1% |
| 514K | $69.6M | 1.1% |
| 922K | $68.6M | 1.1% |
| 1.66M | $68.6M | 1.1% |
| 65K | $68.2M | 1.1% |
| 396K | $66.5M | 1.1% |
| 680K | $65.3M | 1.0% |
| 236K | $65.1M | 1.0% |
| 409K | $62M | 1.0% |
| 660K | $60.5M | 1.0% |
| 571K | $59.1M | 0.9% |
| 151K | $54.8M | 0.9% |
| 849K | $54.5M | 0.9% |
| 185K | $54.3M | 0.9% |
| 1.57M | $50.2M | 0.8% |
| 642K | $49.9M | 0.8% |
| 176K | $49.9M | 0.8% |
| 268K | $48.2M | 0.8% |
Enovis (ENOV)
189K → 106K shares (−44%)
APA Corporation (APA)
728K → 67K shares (−91%)
Kosmos Energy (KOS)
991K → 1.03M shares (+4%)
St. Joe Company (JOE)
4,040 → 34K shares (+754%)
Umh Properties (UMH)
68K → 140K shares (+107%)
Taboola.Com (TBLA)
530K → 425K shares (−20%)
LTC Properties, Inc. (LTC)
75K → 55K shares (−27%)
ESCO Technologies Inc. (ESE)
8,390 → 5,838 shares (−30%)
Omega Healthcare Investors (OHI)
368K → 42K shares (−89%)
Cimpress (CMPR)
51K → 20K shares (−61%)
Omada Health (OMDA)
92K shares
Valaris (VAL)
139K → 28K shares (−80%)
GATX (GATX)
15K → 11K shares (−26%)
Veeco Instruments Inc. (VECO)
159K → 26K shares (−84%)
Amneal Pharmaceuticals (AMRX)
328K → 114K shares (−65%)
Torm (TRMD)
68K → 75K shares (+11%)
Textron (TXT)
45K → 21K shares (−53%)
Steel Dynamics (STLD)
22K → 8,402 shares (−61%)
Virtu Financial, Inc. (VIRT)
111K → 32K shares (−71%)
Relay Therapeutics (RLAY)
339K → 101K shares (−70%)
Agilon Health (AGL)
17K shares
Ingevity, Corp. (NGVT)
19K → 25K shares (+33%)
Olema Pharmaceuticals (OLMA)
114K → 148K shares (+30%)
Iradimed (IRMD)
2,680 → 19K shares (+620%)
United States Lime & Minerals, Inc. (USLM)
6,564 → 18K shares (+167%)
